Gross margin

Haivision Announces Results for the Fourth Quarter and Full Year Ended October 31, 2021

Retrieved on: 
Tuesday, January 25, 2022

Mirko Wicha, Chairman and CEO of Haivision said, "Fiscal 2021 has been our best year ever, beginning with a monumental initial public offering.

Key Points: 
  • Mirko Wicha, Chairman and CEO of Haivision said, "Fiscal 2021 has been our best year ever, beginning with a monumental initial public offering.
  • Revenue of $27.1 million, up 22.3% from $22.1 million in the fourth quarter of fiscal 2020, a record quarterly performance.
  • Fourth quarter revenues of $27.1 million, represented a 22% increase compared to the prior year revenue of $22.1 million in the same period.
  • Haivision will hold a conference call to discuss its fourth quarter financial results on Tuesday,
    To register for the call, please use this link http://www.directeventreg.com/registration/event/5238868 .

Haivision Announces Fiscal 2021 Third Quarter Financial Results

Retrieved on: 
Tuesday, September 14, 2021

MONTREAL, Sept. 14, 2021 /PRNewswire/ - Haivision Systems Inc. ("Haivision" or the "Company") (TSX: HAI), a leading global provider of mission critical, real-time IP video solutions, today announced its third quarter fiscal financial results for the three months and nine months ended July 31, 2021.

Key Points: 
  • MONTREAL, Sept. 14, 2021 /PRNewswire/ - Haivision Systems Inc. ("Haivision" or the "Company") (TSX: HAI), a leading global provider of mission critical, real-time IP video solutions, today announced its third quarter fiscal financial results for the three months and nine months ended July 31, 2021.
  • The Company recorded net income of $1.9 million in the third quarter of fiscal 2021, compared to net income of $2.1 million for the same period in fiscal 2020.
  • Haivision will hold a conference call to discuss its third quarter financial results on Tuesday,
    To register for the call, please use this link http://www.directeventreg.com/registration/event/4638827 .
  • Haivision's consolidated financial statements for the third quarter ended July 31, 2021 are prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board.

Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance

Retrieved on: 
Tuesday, August 3, 2021

The second quarter of 2021 was exceptional for Cerus on numerous fronts.

Key Points: 
  • The second quarter of 2021 was exceptional for Cerus on numerous fronts.
  • Product revenue during the second quarter of 2021 was $31.5 million, compared to $21.5 million during the same period in 2020.
  • Product gross profit increased $4.4 million over the same period in 2020, however, product gross margins on product revenue during the second quarter of 2021 were 51.3% compared to 54.9% for the second quarter of 2020.
  • R&D expenses for the second quarter of 2021 were $17.1 million, compared to $15.6 million for the second quarter of 2020.

Worldwide Mining Cables Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021

16.1.4 Southwire Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)

Key Points: 
  • 16.1.4 Southwire Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.2.4 CSE Cables Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.3.4 General Cable Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.4.4 Priority Wire & Cable Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.5.4 Chint Group Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.6.4 Texan Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.7.4 Nexans Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.8.4 Viakon Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.9.4 Metric Cables Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.10.4 Prysmian Group Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.11.4 Baosheng Group Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.12.4 Caledonian-cables Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.13.4 SKL Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    16.14.4 PUDA Mining Cables Sales, Revenue, Price and Gross Margin (2016-2021)
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210716005339/en/

USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, July 15, 2021

West Palm Beach, FL, July 15, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced preliminary second quarter financial results for the period ended June 30, 2021, reporting strong sequential growth on several fronts.

Key Points: 
  • West Palm Beach, FL, July 15, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced preliminary second quarter financial results for the period ended June 30, 2021, reporting strong sequential growth on several fronts.
  • In the second quarter of 2021, revenue increased 49.9% sequentially to approximately $456,219 compared to first quarter 2021.
  • Gross profit increased 55.5% sequentially to $207,717 or a 45.5% gross margin in second quarter 2021 compared to $133,579 of gross profit or a 43.9% gross margin in first quarter 2021.
  • We had a very strong second quarter and delivered on our prior guidance for both revenue growth and gross margin expansion sequentially compared to the first quarter of 2021.

CBMJ's Revenue Grows 96% YTD, Reporting $1.827M Through June of 2021, in Addition to Achieving Its First Ever Quarterly Sales Exceeding $1.0M

Retrieved on: 
Wednesday, July 7, 2021

In addition, CBMJ recorded the first ever quarterly revenue exceeding $1.0M in Q-2 of 2021.

Key Points: 
  • In addition, CBMJ recorded the first ever quarterly revenue exceeding $1.0M in Q-2 of 2021.
  • The primary drivers of growth came from product sales of the company's flagship e-commerce site Store.flagandcross.com which accounted for 49% of total quarterly revenue.
  • Patriot Depots product income www.patriotdepot.com came in at 29% despite only being fully operational for 75% of the month.
  • Our goal for the remainder of the year is to produce revenue exceeding $500K per month while achieving 10% Net margins."

Regina Miracle 2H Orders Exceed Pre-Pandemic Levels, Drives Full-Year Revenue and Adjusted Net Profit in Fiscal 2021 to Approximately HK$5.97 Billion and HK$175.3 Million Respectively

Retrieved on: 
Wednesday, June 30, 2021

Gross profit declined by 14.1% to approximately HK$1,238.0 million, with gross profit margin at 20.7% (Fiscal 2020: approximately HK$1,440.7 million and 22.7%, respectively), owing to the drop in revenue.

Key Points: 
  • Gross profit declined by 14.1% to approximately HK$1,238.0 million, with gross profit margin at 20.7% (Fiscal 2020: approximately HK$1,440.7 million and 22.7%, respectively), owing to the drop in revenue.
  • This segment contributed HK$3,968.1 million (Fiscal 2020: HK$5,061.4 million), representing a year-on-year decrease of approximately 21.6% and accounting for approximately 66.4% of the overall revenue.
  • Gross profit of the segment amounted to HK$835.4 million with gross profit margin at 21.1% (Fiscal 2020: HK$1,183.8 million and 23.4%, respectively).
  • Gross profit and gross profit margin of the segment were HK$128.3 million and 22.6%, respectively (Fiscal 2020: HK$144.2 million and 21.3%, respectively).

Crescita Therapeutics Announces 9-Country Licensing Agreement with Croma Pharma for Pliaglis®

Retrieved on: 
Monday, June 28, 2021

Croma will promote Pliaglis directly to physicians through its sales network consisting of approximately 130 members across the Territories.

Key Points: 
  • Croma will promote Pliaglis directly to physicians through its sales network consisting of approximately 130 members across the Territories.
  • Crescita will be the sole supplier of Pliaglis under the agreement at a price per unit including a profit margin.
  • Croma expects to launch Pliaglis in most of the Territories throughout 2022.
  • We are thrilled about our new partnership with Croma, a strong player in the international medical aesthetics space, said Serge Verreault, President and CEO of Crescita.

DGAP-News: Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible

Retrieved on: 
Friday, May 28, 2021

The background to this development is, in connection with the realized sales growth, a substantial improvement of the gross margin and a sharply reduced cost level.

Key Points: 
  • The background to this development is, in connection with the realized sales growth, a substantial improvement of the gross margin and a sharply reduced cost level.
  • Excluding the one-time effects, recurring EBITDA in the first three months of 2021 also significantly improved year-on-year to EUR -0.2 million (Q1/2020: EUR -1.4 million).
  • [1] Gross margin = sales revenues +/- change in inventories of finished goods and work in progress less cost of materials / cost of purchased services.
  • This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information.

Global m-Toluidine Market Insights (2020 to 2025) - by Manufacturers, Regions, Technology and Application - ResearchAndMarkets.com

Retrieved on: 
Monday, May 17, 2021

b'16.2.4 Deepak Nitrite M-Toluidine Sales, Revenue, Price and Gross Margin (2016-2021)\n16.3 Chemieorganics Chemical India Pvt.Ltd.\n16.3.3 SWOT Analysis of Chemieorganics Chemical India Pvt.Ltd.\n16.3.4 Chemieorganics Chemical India Pvt.Ltd.

Key Points: 
  • b'16.2.4 Deepak Nitrite M-Toluidine Sales, Revenue, Price and Gross Margin (2016-2021)\n16.3 Chemieorganics Chemical India Pvt.Ltd.\n16.3.3 SWOT Analysis of Chemieorganics Chemical India Pvt.Ltd.\n16.3.4 Chemieorganics Chemical India Pvt.Ltd.
  • M-Toluidine Sales, Revenue, Price and Gross Margin (2016-2021)\n16.4.4 Jiangsu First Chemical M-Toluidine Sales, Revenue, Price and Gross Margin (2016-2021)\n16.5.4 Jiangsu Huaihe Chemicals M-Toluidine Sales, Revenue, Price and Gross Margin (2016-2021)\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210517005387/en/\n'